¶ Aeras Global TB Vaccine Foundation
.jpeg)
This page has moved! Click here to view the most up-to-date version of this page on the White Rose Wiki.
The Aeras Global TB Vaccine Foundation was an American non-profit product development organization based in Rockville, Maryland.
Aeras worked to develop vaccines against tuberculosis with a number of partners including adenoviral vector vaccines with Crucell (now known as Janssen) and second-generation fusion-protein vaccines with Statens Serum Institut.
¶ History
Aeras was founded in 1997 to “help develop new concepts and tools to control the global TB epidemic.”[1]
In February 2004, Aeras received a 5-year US$82.9 million grant from the Bill & Melinda Gates Foundation. Aeras and the Gates Foundation co-funded an “infant and adolescent TB Vaccine Site preparation study” alongside the European & Developing Countries Clinical Trials Partnership (EDCCTP) at the Infectious Diseases Institute in Uganda.[2]
¶ Organization
Aeras was partnered with the Medicines for Malaria Venture to develop antimicrobial products.[3]
¶ Funding
- Australian Aid
- Bill & Melinda Gates Foundation
- Centers for Disease Control and Prevention (CDC)
- China National Biotec Group (CNBG)
- Chinese Center for Disease Control and Prevention (CCDC)
- Crucell
- Danish International Development Agency (DANIDA)
- Dutch Ministry of Foreign Affairs
- Emergent BioSolutions
- European & Developing Countries Clinical Trials Partnership (EDCCTP)
- Food and Drug Administration (FDA)
- Geisel School of Medicine at Dartmouth
- GlaxoSmithKline
- Global Health Innovative Technology Fund (GHITF)
- Infectious Disease Research Institute (IDRI)
- Okairos
- Oregon Health & Science University (OHSU)
- Pasteur Institute of Lille
- Research Council of Norway
- Sanofi Pasteur
- Statens Serum Institut
- Stop TB Partnership
- TuBerculosis Vaccine Initiative (TBVI)
- UK Aid
- United States Department of Defense (DoD)
- University of Oxford
- Wellcome Trust
¶ Network
Participants in Aeras' clinical trial network included:
- Aurum Institute
- Centre for Infectious Disease Research in Zambia (CIDRZ)
- Children’s Infectious Diseases Clinical Research Unit (KID-CRU)
- Desmond Tutu HIV Center
- HIV Vaccine Trials Network (HVTN)
- International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT)
- Kenya Medical Research Institute (KEMRI)
- National Institute for Medical Research, Tanzania (NIMR)
- Perinatal HIV Research Unit (PHRU)
- Setshaba Research Centre
- South African Tuberculosis Vaccine Initiative (SATVI)
- TASK Applied Science
- University of Cape Town Lung Institute (UCTLI)
- Wellcome Centre for Infectious Diseases Research in Africa
- Wits Reproductive Health and HIV Institute (Wits RHI)
- Zambart
¶ External links
About Aeras. Aeras Global TB Vaccine Foundation. Retrieved December 7, 2006, from https://web.archive.org/web/20061207055538/http://www.aeras.org/about/index.html ↩︎
Research Projects. (2017, August). Infectious Diseases Institute. https://web.archive.org/web/20230517200932/https://idi.mak.ac.ug/wp-content/uploads/2017/08/Research-Projects.pdf ↩︎
Other product development partnerships (PDPs). Medicines for Malaria Venture. Retrieved July 17, 2022, from https://web.archive.org/web/20220717220929/https://www.mmv.org/other-product-development-partnerships-pdps ↩︎
Funders and Partners. Aeras. Retrieved July 24, 2018, from http://archive.today/2018.07.24-024017/http://www.aeras.org/pages/funders ↩︎
Aeras Global TB Vaccine Foundation - Rockville, USA. Bionity. Retrieved May 12, 2023, from http://archive.today/2023.05.12-171636/https://www.bionity.com/en/associations/20656/aeras-global-tb-vaccine-foundation.html ↩︎